PSA has several limitations because of its well-known non-cancer specificity, with raising levels for many other urological conditions such as infections, inflammation or benign prostatic hyperplasia, resulting in high false-positive rates1. The gene discussed is KLK3; the disease is benign prostatic hyperplasia.